BRCA mutation does not change survival rate
This article was originally published in Clinica
In what could influence patient management, a New England Journal of Medicine (NEJM) study reports that breast cancer patients carrying either of the BRCA gene variants are at no higher risk of dying from the disease than non-carriers with breast cancer. In addition, carriers of the BRCA 1 mutation were more likely to respond well to chemotherapy than non-carriers.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.